1. Home
  2. /
  3. Acceptability
  4. /
  5. Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa

Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa

Description

The workshop aimed to align stakeholders on priority populations and delivery strategies for future TB vaccines, identify evidence needs to inform national policy decision-making, and outline actions required to ensure timely and equitable introduction. 
TB vaccine theme
Acceptability, Accessibility, Availability
Community engagement, Economic impact/cost-effectiveness, FInancing strategies, Implementation strategies and feasibility, Policy and frameworks

Project details

Country
South Africa
Timeline
2025-2026
Target group
Adolescents, Adults, PLHIV, vulnerable populations
Vaccine
M72/AS01e, MTBVAC
Type of protection of vaccine
Prevention of disease
Type of research
Other, Qualitative
Partners involved
Africa Health Research Institute, Aurum institute, BMGF, SATVI, South African National Department of Health, TB Proof, University of Cape Town, University of the Witwatersrand, WHO, WHO South Africa
Type of project
policy and frameworks, research
Funder
BMGF
Civil Society
TB Proof
Governmental Body
South African National Department of Health

Resources

Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa: policy, evidence, and system readiness insights from a national workshop

Contact

Priashni Subrayen
psubrayen@auruminstitue.ord
Click to copy link of this header Menu